Results 41 to 50 of about 11,369 (213)

A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant

open access: yesFrontiers in Immunology, 2020
Therapeutics based on fusing a protein of interest to the IgG Fc domain have been enormously successful, though fewer studies have investigated the vaccine potential of IgG fusions.
Andrew G. Diamos   +13 more
doaj   +1 more source

Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1

open access: yesFrontiers in Immunology, 2021
Immune checkpoint inhibitors such as anti-PD-1 have revolutionized the field of oncology over the past decade. Nevertheless, the majority of patients do not benefit from them.
Victor Cervera-Carrascon   +21 more
doaj   +1 more source

Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report

open access: yesFrontiers in Oncology, 2018
Melanoma is considered an aggressive malignancy with a tendency of forming metastasis in the brain. Less than 10% of all melanoma cases present with unknown primary tumor location.
Guna Proboka   +5 more
doaj   +1 more source

Lung cancer and oncolytic virotherapy——enemy's enemy

open access: yesTranslational Oncology, 2023
Lung cancer is one of the malignant tumors that seriously threaten human health worldwide, while the covid-19 virus has become people's nightmare after the coronavirus pandemic. There are too many similarities between cancer cells and viruses, one of the
Zhang Li   +3 more
doaj   +1 more source

Recombinant Myxoma Virus-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling

open access: yesPharmaceutics, 2020
Complex dermal wounds represent major medical and financial burdens, especially in the context of comorbidities such as diabetes, infection and advanced age.
Jordan R. Yaron   +10 more
doaj   +1 more source

Current strategies in engaging oncolytic viruses with antitumor immunity

open access: yesMolecular Therapy: Oncolytics, 2021
Oncolytic virotherapy has produced promising yet limited results in preclinical and clinical studies. Besides direct oncolytic activity, a significant therapeutic mechanism of oncolytic virotherapy is the induction of tumor-specific immunity ...
Drew Ashton Boagni   +2 more
doaj   +1 more source

Canine Distemper Virus‐Induced Transcriptional Modulation of Canine Histiocytic Sarcoma Cells in an In Vitro Model of Tumour Zones [PDF]

open access: yesJ Cell Mol Med
ABSTRACT Canine distemper virus (Onderstepoort strain; CDVOnd) exhibits potential oncolytic properties. However, the detailed molecular mechanisms remain undetermined so far. This study investigated the influence of a CDVOnd infection and various culture conditions on gene expression patterns in canine histiocytic sarcoma (DH82) cells at different time
Asawapattanakul T   +6 more
europepmc   +2 more sources

Enhancing oncolytic virotherapy: Observations from a Voronoi Cell-Based model [PDF]

open access: yes, 2020
Oncolytic virotherapy is a promising cancer treatment using genetically modified viruses. Unfortunately, virus particles rapidly decay inside the body, significantly hindering their efficacy.
Kim, PS   +3 more
core   +1 more source

Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy [PDF]

open access: yes
Oncolytic virotherapy is a promising immunotherapy approach for cancer treatment, utilizing viruses to preferentially infect and eliminate cancer cells while stimulating immune responses.
Daemen, Toos; id_orcid   +1 more
core   +2 more sources

Remote Control of Light-Triggered Virotherapy

open access: yes, 2017
Clinical virotherapy has been successfully approved for use in cancer treatment by the U.S. Food and Drug Administration; however, a number of improvements are still sought to more broadly develop virotherapy.
楊泮池   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy